Docoh
Loading...

62 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
in person or by proxy at the Meeting and voting on the proposal will be required for approval. We believe that the experience, abilities and commitment … ”), both related parties, which provide a revolving commitment of up to $700,000 each ($1.4 million total). Our CEO is also the CEO and Managing
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
”) and CorLyst, LLC (“CorLyst”, and, together with DKBK, collectively, “Lenders”), both related parties, which provide a revolving commitment of up
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
Payments made by investor for clinical trial costs Pledged shares of common stock forfeited upon revised research funding commitment Stock-based … (forfeited)/issued in connection with a clinical trial funding commitment The accompanying notes are an integral part of these consolidated
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
a revolving commitment of up to $700,000 each ($1.4 million total). Under the LOC Agreements, all funds borrowed bear interest at an annual rate of 8 … stockholders and related parties DKBK and CorLyst, which provide a revolving commitment of up to $700,000 each ($1.4 million total). Under the LOC
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
Filed Pursuant to Rule 424(b)(4) Registration No. 333-235511 4,800,000 Shares of Common Stock This is a firm commitment public offering … (“CorLyst”, and, together with DKBK, collectively, “Lenders”), both related parties, which provide a revolving commitment of up to $700,000 each ($1.4
S-1/A
9bod hhf9oql049xsyp2
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
phetuclagh198v
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-2.1
t4mchy
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-3.2
exyry a22
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.13
ry0bbc
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.11
6bu0 wr8ygrb7
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.12
67owvkv2lyo
16 Sep 20
IPO registration (amended)
8:00pm
8-K
EX-10.1
j33rtyn4g3m peoel3b
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
ui082j viipreen1j74
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
eh1er 24c
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
ae6eq2ciuph2do nowlw
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
10-Q
1dgsbu4
5 Aug 20
Quarterly report
3:32pm
S-1/A
0md1r 8o7
17 Jul 20
IPO registration (amended)
5:25pm
10-Q
blxnqso4mkkbqr
15 May 20
Quarterly report
1:23pm
10-K
fnj 5vpw48hsm8
5 Mar 20
Annual report
7:00pm